Tag: NASDAQ:ARRY

Finance

Shining on Major News : ProQR Therapeutics (NASDAQ:PRQR), Array BioPharma (NASDAQ:ARRY), Brooks Automation (NASDAQ:BRKS), Taubman Centers, Inc. (NYSE:TCO),GERN

ProQR Therapeutics N.V. (NASDAQ:PRQR) announced today the closing of its initial public offering of 8,625,000 ordinary shares at a public offering price of $13.00 per share, which includes the exercise in full by the underwriters of their option to purchase 1,125,000 additional ordinary shares. The aggregate net proceeds to the Company, after underwriting discounts and commissions and other estimated offering expenses, will be approximately $102 … Continue reading Shining on Major News : ProQR Therapeutics (NASDAQ:PRQR), Array BioPharma (NASDAQ:ARRY), Brooks Automation (NASDAQ:BRKS), Taubman Centers, Inc. (NYSE:TCO),GERN

Kevin Long
Finance

Fast Moving Stocks: Macy’s, Inc. (NYSE:M), Array BioPharma (NASDAQ:ARRY), British American Tobacco (NYSEMKT:BTI), Crossroads Systems, Inc. (NASDAQ:CRDS), Clovis Oncology, Inc. (NASDAQ:CLVS)

Macy’s, Inc. (NYSE:M) is a chain of departmental stores that sells an assortment of fashion products for both men and women.Best Buy Co Inc (NYSE:BBY) sells electronics such as computers, cellphones, video games, and several other tech products. On the other hand, Time Warner Cable Inc (NYSE:TWC) is a cable telecommunications company that operates in many US States.Macy’s, Inc. (NYSE:M) belongs to Services sector. Its … Continue reading Fast Moving Stocks: Macy’s, Inc. (NYSE:M), Array BioPharma (NASDAQ:ARRY), British American Tobacco (NYSEMKT:BTI), Crossroads Systems, Inc. (NASDAQ:CRDS), Clovis Oncology, Inc. (NASDAQ:CLVS)

Kevin Long
Finance

Morning Buzz: PharMerica (NYSE:PMC), Array BioPharma (NASDAQ:ARRY), Mobile Mini (NASDAQ:MINI), Genocea Biosciences, Inc. (NASDAQ:GNCA), Health Care REIT, Inc. (NYSE:HCN)

PharMerica Corporation (NYSE:PMC) reported its financial results for the second quarter and six months ended June 30, 2014. Revenues for the second quarter of 2014 were $448.6 million compared with $430.8 million for the second quarter of 2013. The increase in revenue was primarily the result of the fourth quarter 2013 acquisitions and branded drug price inflation, and was partially offset by previously disclosed bed … Continue reading Morning Buzz: PharMerica (NYSE:PMC), Array BioPharma (NASDAQ:ARRY), Mobile Mini (NASDAQ:MINI), Genocea Biosciences, Inc. (NASDAQ:GNCA), Health Care REIT, Inc. (NYSE:HCN)

Adam Keintzel
Finance

NASDAQ losers: Chelsea Therapeutics International (NASDAQ:CHTP), Pharmacyclics (NASDAQ:PCYC), ZIOPHARM Oncology (NASDAQ:ZIOP), Array Biopharma (NASDAQ:ARRY)

Some drugs that have gained approval this year so far include AstraZeneca’s Myalept (complications of leptin deficiency) and Farxiga (type II diabetes), Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) (to treat neurogenic orthostatic hypotension), BioMarin’s Vimizim (Morquio A syndrome) and Vanda Pharma’s Hetlioz. Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) stock performance was -5.75% in last session and finished the day at $4.92. Traded volume was 3.02million shares in … Continue reading NASDAQ losers: Chelsea Therapeutics International (NASDAQ:CHTP), Pharmacyclics (NASDAQ:PCYC), ZIOPHARM Oncology (NASDAQ:ZIOP), Array Biopharma (NASDAQ:ARRY)

John Meady
Finance

Biotech Stocks Touched New Lows: Onconova Therapeutics Inc (NASDAQ:ONTX), Array Biopharma (NASDAQ:ARRY), AVEO Pharmaceuticals (NASDAQ:AVEO), Infinity Pharmaceuticals (NASDAQ:INFI)

Onconova Therapeutics Inc (NASDAQ:ONTX)’s share price has entered into oversold territory with an RSI value of 19.3. The Zacks Consensus Estimate for Onconova Therapeutics Inc (NASDAQ:ONTX) for the full year period has improved 75 cents over the past two months to $-2.09 per share. Currently, Onconova Therapeutics Inc (NASDAQ:ONTX) has a Zacks Rank #2 (Buy), suggesting that now might be a good time to get … Continue reading Biotech Stocks Touched New Lows: Onconova Therapeutics Inc (NASDAQ:ONTX), Array Biopharma (NASDAQ:ARRY), AVEO Pharmaceuticals (NASDAQ:AVEO), Infinity Pharmaceuticals (NASDAQ:INFI)

Mark Doerr
BioTech, Stock Movers

Array Biopharma (NASDAQ:ARRY) Jumping Pre-Bell, SolarCity (NASDAQ:SCTY), Nu Skin Enterprises (NYSE:NUS) Slip

Array BioPharma (NASDAQ:ARRY) was up more than 9% in pre-market trade after reporting positive study results for its asthma treatment. The company said, ARRY-502, an oral CRTh2 antagonist, was studied in a 184-patient placebo-controlled, randomized, double-blind Phase 2 trial in mild to moderate persistent allergic asthma, a population representing more than 12 million patients in the U.S. ARRY-502 met the primary endpoint in the trial, … Continue reading Array Biopharma (NASDAQ:ARRY) Jumping Pre-Bell, SolarCity (NASDAQ:SCTY), Nu Skin Enterprises (NYSE:NUS) Slip

John Meady